Comparative Study of EDP-420 Versus Another Antibiotic in the Treatment of Community Acquired Pneumonia

NCT00270517 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

250

Enrollment

INDUSTRY

Sponsor class

Conditions

Community Acquired Pneumonia

Interventions

DRUG: EDP-420 / Duration of Treatment - 3 days
DRUG: Telithromycin / Duration of Treatment - 7 days

Sponsor

Enanta Pharmaceuticals, Inc